2506results about How to "Avoid cross contamination" patented technology

A portable medical diagnostic instrument includes an instrument head and a handle portion having an open-ended receiving cavity. A compact illuminator defined by a housing retaining a miniature light source and a power supply is releasably fitted within the open-ended receiving cavity of the handle portion wherein the light source of the illuminator is optically coupled with the instrument on assembly therewith. The handle portion can be integral with the instrument or releasably attached. The handle portion according to at least one version is made from a plastic or other suitable material, permitting disposability and/or single patient use. In one version, the handle portion is flexibly deformable, at least partially, to facilitate release of the portable illuminator.

The present invention relates to new methods for manufacturing photovoltaic devices and an apparatus for practicing those methods of manufacture. The present invention employs a transfer-through system for advancing work piece substrates through an integrated apparatus of multiple treatment chambers that control each of the manufacturing processes.

A hypodermic syringe and a plurality of single use cartridges able to be successively loaded into said syringe for providing rapid dispensing of a medicant to numerous users without possibility of contamination. The cartridges are continuously fed through the syringe for the quick and efficient inoculation of patients. An operator inserts a needle into a patient by pushing in a trigger. Prior to the needle being inserted into the patient, a disinfectant is dispersed from the cartridge to maintain sterility. An operator then pushes in a plunger forcing the medication through the needle into the patient. The plunger is pulled back into its original location after use. The needle is pulled back with the plunger out of the patient's skin and back into the cartridge. A new cartridge on a clip is then advanced into the syringe for use in inoculating the next patient needing medication. The syringe and cartridge dispenser further maintains a sterile environment during successive vaccinations reducing the transmission of any disease from patient to patient.

An antibacterial/anti-inflammatory composition and method wherein the pairing of synergistic active ingredients with a natural enhancer for a more efficacious formulation for topical application treatments is used. Active ingredients hydrocortisone 1% and benzoyl peroxide 10% are paired with Emu Oil to increase the percentage of absorption of the ingredients through the skin. The preferred method of use of the composition is via a dual-pharmaceutical delivery syringe that isolates components (1) having a barrel (9), a piston (8) and a commonly shared split nozzle (5). The barrel (9) has two syringe compartments (2) and (14) attached to one another and connected to the split nozzle (5). The piston (8) has two plungers (6) connected via a bridge (12). A user applies force to the piston (8), dispersing the substances in the syringe compartments (2) and (14) through the respective sides of the split nozzle (5) onto the user's skin. The user then massages the substances into the skin for “hands-on healing.”

Reconfigurable control systems for beverage dispensers, beverage dispensers with a reconfigurable control panel, beverage dispensers that sequence the dispensing of beverage fluids that make up a selected beverage, beverage dispensers that allow for the dispensing of user customized beverages, and related methods for dispensing a beverage fluid are provided. A reconfigurable control system includes a control panel having multiple sensing regions, user reconfigurable switches used to select a control panel configuration, and a control unit operatively coupled with the control panel and the user reconfigurable switches. Each of the sensing regions is assigned to a key of the selected control panel configuration or deactivated. The keys of the selected control panel configuration receive user input to select a beverage and/or a beverage additive.

Disclosed herein is a SERS sensing surface device comprising a substrate supporting a plurality of nano structures, an exposed sensing surface upon the nano structures, wherein said surface includes at least one active SERS nano surface and at least one inactive SERS nano surface established in proximity to the active SERS nano. Also disclosed are methods for forming the array device, systems based on the array device, as well as methods for performing SERS with the array device.

The invention features methods of making devices, or “platens”, having a high-density array of through-holes, as well as methods of cleaning and refurbishing the surfaces of the platens. The invention further features methods of making high-density arrays of chemical, biochemical, and biological compounds, having many advantages over conventional, lower-density arrays. The invention includes methods by which many physical, chemical or biological transformations can be implemented in serial or in parallel within each addressable through-hole of the devices. Additionally, the invention includes methods of analyzing the contents of the array, including assaying of physical properties of the samples.

A monitoring network system for inspecting and controlling harmful substances includes probe assemblies that each includes a sensor comprising nano structured surfaces or nano particles in a solution, configured to adsorb molecules of a sample material captured adjacent to the sensor, a laser that can emit a laser beam to illuminate the molecules adsorbed to the nano structured surfaces, a spectrometer that can produce spectral data from light scattered by the molecules adsorbed to the nano structured surfaces, and a ID reader that can retrieve identification information about the sample material. A central office can determine a spectral signature matching spectral signatures stored in a database and to identify a harmful substance in the sample material. An alert and response system can send out an alert signal about the sample material when the harmful substance is identified in the sample material.

The invention discloses a butt joint type operation patient transfer trolley and belongs to the technical field of medical apparatus. The butt joint type operation patient transfer trolley comprises a transverse moving bed and a transfer trolley. The transverse moving bed with a tiltable bed top is disposed on a transfer trolley plate of the transfer trolley and locked by a bed locking device. The transfer trolley comprises a transfer trolley body, a transfer trolley base and a lifting device. The transfer trolley body is supported on the transfer trolley base through the lifting device. The transverse moving bed mainly comprises a transverse moving bed frame, a bed board, an air cushion and rollers. Inflation of the air cushion enables the bed board to tilt. By the butt joint technology, an operation patient along with the moving bed is transferred from the transfer trolley outside an operating room to the transfer trolley in the operating room, cross infection is avoided, operating environments are kept clean, and operating safety is increased. By the moving bed with the tiltable bed top, the patient can be transferred from the operation patient transfer trolley to an operating table conveniently and time- and labor-savingly. The butt joint type operation patient transfer trolley is suitable for transferring seriously-injured patients from ambulances to operating rooms of hospitals.

The invention discloses an automated instrument applied to nucleic acid extraction and continuous operation process of a mass spectrum sample application chip in biomass spectrometry analysis of a nucleic acid sample. The automated instrument comprises three main devices, namely, a nucleic acid extraction and purification device, a nucleic acid liquor relief distributing device and a mass spectrum chip sample application device, wherein nucleic acid in body fluid is extracted by using a magnetic bead method, a mechanical arm is utilized to complete a nucleic acid extraction action, the extracted nucleic acid is dispensed onto a sample board through a dispenser, a pipettor is used for transferring the sample board onto a chip sample application instrument, and the mass spectrum and relatedinformation of the nucleic acid are obtained through laser sampling of a mass spectrometer, so that the nucleic acid is analyzed rapidly, directly and continuously. The automated instrument is high-precision in controlling the volume of dispensed liquor, high-cleanliness in controlling the quality of the dispensed liquor and high-efficiency in meeting sample application requirements of large-batch samples; meanwhile, the samples are uniformly distributed under the control of a computer program, volume errors and possible foreign pollution caused by manual operation are avoided, and the speed and efficiency in sample application are increased at the same time.

The invention relates to a method for separating and extracting stem cells from a placenta, umbilical cord or adipose tissue, which comprises the following process steps: firstly mixing the placenta, umbilical cord or adipose tissue and a cell maintenance fluid according to the proportion by weight of 2.5-4:1, putting the mixture into a tissue crushing barrel, adding collagenase after crushing, uniformly mixing, hatching at the temperature of 37 DEG C, filtering, adding a precipitator, sucking a supernatant fluid after settling, centrifuging, removing the supernatant fluid, adding concentrated cells into a liquid of diatrizoate sodium-ficoll 400#, then centrifuging, collecting 10-15 ml of intermediate cell layer, washing with the cell maintenance fluid, counting the collected cells, and providing the cells for clinical use when the cell survival ratio is more than or equal to 95 percent. The invention not only realizes the separation and the extraction of all stem cells from the placenta, umbilical cord or adipose tissue, but also realizes industrialized production, and enables doctors to conveniently, safely and canonically obtain the adult stem cells in clinic and use the adult stem cells for treating the diseases of patients as using medicaments, thereby solving the bottleneck problem of difficult obtainment of adult stem cells in clinic and popularizing a cell treatment technology.

A transport network includes a flexible topology for internally defining transport elements. The transport elements each include a port group having a plurality of geographically distributed ports from the transport network. Point-to-multipoint connectivity is defined between the ports in a port group. An identifier represents the port group as a single element to internal and/or external elements for protocol exchanges.

An adhesive patch is provided wherein the patch includes a porous backing having a front side and a back side. The patch also includes a therapeutic formulation located on the front side of the backing. The backing includes a flexible sheet of water insoluble porous material. The therapeutic formulation includes a combination of a antiviral agent useful for treating a viral infection in a mammal (e.g., human), a medicament that relieves topical discomfort, an adhesive, and a solvent. The solvent can preferably include a fragrance.

A double-layer shutter control method of a multi-sputtering system provided with three targets in a single chamber and a double-layer rotating shutter mechanism having shutter plates which independently rotate and have holes formed therein, comprising selecting a target by a combination of holes of a first shutter plate and a second shutter plate and uses the selected target for a pre-sputtering step and a main sputtering step with continuous discharge so as to deposit a film on a substrate, whereby it is possible to prevent cross-contamination between targets due to target substances etc. deposited on the shutter plates.

The present invention provides, in at least one embodiment, a loading device, system and method that loads aggregate cells into an encapsulation device for implanting into a patient. The loading system uses negative pressure from a low pressure pump in a closed system to improve safety and cell viability while allowing for even loading of the encapsulation device.